![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | ![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() Quanterix Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches. | ||
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 1990 | Founding Date 2007 |
Type | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB | Locations San Francisco, US HQ Bozeman, US | Locations Ewing Township, US HQ | Locations Billerica, US HQ Baltimore, US Philadelphia, US San Diego, US San Francisco, US Seattle, US |
Employees | Employees 156% decrease | Employees 2216% increase | Employees 4 | Employees 24840% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 75 m | Valuation ($) N/A | Valuation ($) 506.2 m |
Funding | ||||
Total funding raised | Total funding raised $ 17m | Total funding raised $ 17.8m | Total funding raised N/A | Total funding raised $ 96.5m |

SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View companyCellOxess is a company that provides healthcare and biotechnology services.
View company
Quanterix is a platform for single molecule analysis that supports clinical diagnostics, drug development, and life science researches.
View company